Usage of skin care products and risk of rheumatoid arthritis: Results from the Swedish EIRA study

Arthritis Research and Therapy

Volumn 14, Issue 1, 2012, Pages

  Sverdrup, Berit M ^a,b   Källberg, Henrik ^c   Klareskog, Lars ^a   Alfredsson, Lars ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Mälarsjukhuset ^*  (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; MINERAL OIL; RHEUMATOID FACTOR; ANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; SKIN CREAM;

ADULT; AGED; ARTICLE; BACK; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FACE; FEMALE; FOOT; HAND; HIGH RISK POPULATION; HUMAN; LEG; LIFESTYLE; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; NECK; OCCUPATIONAL EXPOSURE; POPULATION BASED CASE CONTROL STUDY; RESIDENTIAL AREA; RHEUMATOID ARTHRITIS; SELF REPORT; SKIN CARE; SWEDEN; THORAX; ADOLESCENT; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ANTIBODIES; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; COSMETICS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MINERAL OIL; OCCUPATIONAL EXPOSURE; PEPTIDES, CYCLIC; QUESTIONNAIRES; RISK FACTORS; SKIN CREAM; SWEDEN; YOUNG ADULT;

EID: 84859093783     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3749     Document Type: Article

References (24)

1. Rooney BK, Silman AJ. Epidemiology of the rheumatic diseases. Curr Opin Rheumatol 1999, 11:91-97. 10.1097/00002281-199903000-00002, 10319210.
2. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000, 43:30-37. 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B, 10643697.
3. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987, 30:1205-1213. 10.1002/art.1780301102, 2446635.
4. Jawaheer D, Gregersen PK. Rheumatoid arthritis. The genetic components. Rheum Dis Clin North Am 2002, 28:1-15. v, 10.1016/S0889-857X(03)00066-8, 11840692.
5. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FA, Zhernakova A, Hinks A, Guiducci C, Chen R, Alfredsson L, Amos CI, Ardlie KG, , Barton A, Bowes J, Brouwer E, Burtt NP, Catanese JJ, Coblyn J, Coenen MJ, Costenbader KH, Criswell LA, Crusius JB, Cui J, de Bakker PI, De Jager PL, Ding B. BIRAC Consortium Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis loci. Nat Genet 2010, 42:508-514. 10.1038/ng.582, 20453842, BIRAC Consortium.
6. Symmons DP, Bankhead CR, Harrison BJ, Brennan P, Barrett EM, Scott DG, Silman AJ. Blood transfusion, smoking, and obesity as risk factors for the development of rheumatoid arthritis: results from a primary care-based incident case-control study in Norfolk, England. Arthritis Rheum 1997, 40:1955-1961. 10.1002/art.1780401106, 9365083.
7. Stolt P, Kallberg H, Lundberg I, Sjogren B, Klareskog L, Alfredsson L. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2005, 64:582-586. 10.1136/ard.2004.022053, 1755463, 15319232.
8. Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J, Rönnelid J, Harris HE, Ulfgren AK, Rantapää-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38-46. 10.1002/art.21575, 16385494.
9. Padyukov L, Silva C, Stolt P, Alfredsson L, Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004, 50:3085-3092. 10.1002/art.20553, 15476204.
10. Kohashi O, Pearson CM, Beck FW, Narita T, Kotani S. Arthritogenicity in rats of cell walls from several streptococci staphylococci and two other bacteria. Proc Soc Exp Biol Med 1976, 152:199-203.
11. Lorentzen JC. Identification of arthritogenic adjuvants of self and foreign origin. Scand J Immunol 1999, 49:45-50. 10.1046/j.1365-3083.1999.00463.x, 10023856.
12. Wooley PH, Seibold JR, Whalen JD, Chapdelaine JM. Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum 1989, 32:1022-1030. 10.1002/anr.1780320812, 2765002.
13. Cannon GW, Woods ML, Clayton F, Griffiths MM. Induction of arthritis in DA rats by incomplete Freund's adjuvant. J Rheumatol 1993, 20:7-11.
14. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun 1991, 4:871-880. 10.1016/0896-8411(91)90050-M, 1812893.
15. Kleinau S, Erlandsson H, Klareskog L. Percutaneous exposure of adjuvant oil causes arthritis in DA rats. Clin Exp Immunol 1994, 96:281-284. 1534890, 8187335.
16. Sverdrup B, Klareskog L, Kleinau S. Common commercial cosmetic products induce arthritis in the DA rat. Environ Health Perspect 1998, 106:27-32. 10.1289/ehp.9810627, 1532946, 9417771.
17. Kumagai Y, Shiokawa Y, Medsger TA, Rodnan GP. Clinical spectrum of connective tissue disease after cosmetic surgery. Observations on eighteen patients and a review of the Japanese literature. Arthritis Rheum 1984, 27:1-12. 10.1002/art.1780270101, 6691849.
18. Sverdrup B, Källberg H, Bengtsson C, Lundberg I, Padyukov L, Alfredsson L, Klareskog L, . Epidemiological Investigation of Rheumatoid Arthritis Study Group Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arthritis Res Ther 2005, 7:R1296-R1303. 10.1186/ar1824, 1297574, 16277683, Epidemiological Investigation of Rheumatoid Arthritis Study Group.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
20. Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, Alfredsson L, . EIRA Study Group Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003, 62:835-841. 10.1136/ard.62.9.835, 1754669, 12922955, EIRA Study Group.
21. Klareskog L, Nordmark B, Lindblad S. On the organization of an early arthritis clinic. Best Pract Res Clin Rheumatol 2001, 15:1-15. 10.1053/berh.2000.0122, 11358411.
22. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992, 39:225-235. 10.1111/j.1399-0039.1992.tb01940.x, 1357775.
23. Rönnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 2005, 64:1744-1749. 10.1136/ard.2004.033571, 1755292, 15843452.
24. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976, 103:226-235.